Opening of a second plant
Tchaikapharma’s second plant was opened on March 17th, 2005, fully equipped with state-of-the art laboratory machinery for physical and chemical control and microbiology. The total value of the plant was BGN 15 million (EUR 7.7 mln.)
The opening ceremony brought many prominent government officials, with the Bulgarian President Georgi Parvanov as a guest of honor, as well as representatives of multinational pharmaceutical corporations who showed interest in contracting part of their manufacture to the company.
*The company product portfolio continued to expand with Akinestat (biperiden hydrochloride), Diltiazem-Tchaikapharma (diltiazem), Doxazosin-Tchaikapharma (doxazosin), Verapamil-Tchaikapharma 80 mg (verapamil), Verapamil-Tchaikapharma 240 mg (verapamil).
*F. Hoffmann-La Roche contracted manufacture of a third product – Madopar HBS 125 mg capsules.
Expansion of manufacturing area
Due to the company’s fast market entry, the third expansion of the manufacturing area started in late 2005 with additional 663 square meters. Fifth and sixth Uhlmann blistering lines were added.
Company registration in Macedonia
After a successful GMP inspection by the Macedonian Drug Agency of the recently inaugurated plant, the registration of Tchaikapharma medicines started in the Republic of Macedonia.
Funding of veteran monument
To celebrate the 120th anniversary of the victory in the battle near Slivnitsa of the Bulgarian army in the Serbian-Bulgarian war in 1885, Tchaikapharma High Quality Medicines Inc. erected a monument of Bulgarian officers, sergeants and soldiers fallen in the war. Tchaikapharma funded the entire project and organized an inauguration on Nov. 7. The monument was inaugurated in the presence of the Vice President of the Republic of Bulgaria, war veterans, representatives of military organizations and numerous citizens.